Skip to content

Investigating the effect of virtual reality glasses on the intensity of pain and anxiety caused by hysterosalpingography of infertile women

Investigating the effect of virtual reality glasses on the intensity of pain and anxiety caused by hysterosalpingography of infertile women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241001063221N2
Enrollment
100
Registered
2025-02-07
Start date
2025-02-20
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women undergoing hysterosalpingography. Female infertility

Interventions

Intervention 1: Intervention group: Virtual reality glasses will be provided to the intervention group at the beginning of the hysterosalpingography for 20 minutes. The virtual reality game, which is

Sponsors

Assistant Researcher (Research and Technology) Urmia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: Definite diagnosis of infertility (primary) by a gynecologist, First experience of hysterosalpingography, Age 18-49 years, Candidate for hysterosalpingography with infertility indication.

Exclusion criteria

Exclusion criteria: History of seizures and epilepsy Impaired vision and hearing

Design outcomes

Primary

MeasureTime frame
Severity of pain caused by hysterosalpingography. Timepoint: The pain intensity scale will be used immediately after the completion of hysterosalpingography in the two control and intervention groups. Method of measurement: Visual Pain Scale.

Secondary

MeasureTime frame
Severity of anxiety caused by hysterosalpingography. Timepoint: The anxiety scale will be used before and immediately after the completion of hysterosalpingography in both the control and intervention groups. Method of measurement: Spielberger Overt Anxiety Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSarah Kazemzadeh

Oroumia University of Medical Sciences

Samira_barjaste_70@yahoo.com+98 44 3348 4543

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026